APGE logo

Apogee Therapeutics, Inc. (APGE) CAPEX

Annual CAPEX:

$1.15M+$985.00K(+589.82%)
December 31, 2024

Summary

  • As of today, APGE annual capital expenditures is $1.15 million, with the most recent change of +$985.00 thousand (+589.82%) on December 31, 2024.
  • During the last 3 years, APGE annual CAPEX has risen by +$1.15 million (+100.00%).
  • APGE annual CAPEX is now at all-time high.

Performance

1-Year Change

+589.82%

3-Year Change

+100%

5-Year Change

+100%

15-Year Change

+100%

APGE CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

57.36%
APGE annual capital expenditures is higher than 57.36% of companies in Healthcare sector

Range

All-Time High

$1.15M
APGE annual capital expenditures is currently at an all-time high

3-Year Low

$0.00
APGE annual capital expenditures is currently >+9900.00% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
APGE previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

Mar 2, 2026
APGE next annual earnings announcement is scheduled for Mar 2, 2026

OtherAPGEcash flow metrics

Annual FCF

-$172.33M
APGE annual free cash flow is -$172.33 million

Annual CFO

-$171.17M
APGE annual cash from operations is -$171.17 million

Annual CFI

-$300.46M
APGE annual cash from investing is -$300.46 million

Annual CFF

$495.11M
APGE annual cash from financing is $495.11 million

Quarterly CAPEX:

$0.00-$768.00K(-100.00%)
September 30, 2025

Summary

  • As of today, APGE quarterly capital expenditures is $0.00, with the most recent change of -$768.00 thousand (-100.00%) on September 30, 2025.
  • Over the past year, APGE quarterly CAPEX has dropped by -$751.00 thousand (-100.00%).
  • APGE quarterly CAPEX is now -100.00% below its all-time high of $4.32 million, reached on March 31, 2025.

Performance

3-Month Change

-100%

1-Year Change

-100%

3-Year Change

0%

5-Year Change

0%

APGE Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

29.26%
APGE quarterly capital expenditures is higher than 29.26% of companies in Healthcare sector

Range

All-Time High

$4.32M
APGE quarterly capital expenditures is currently -100.00% below its historical high of $4.32 million

3-Year Low

$0.00
APGE quarterly capital expenditures is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
APGE previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Mar 2, 2026
APGE next earnings announcement is scheduled for Mar 2, 2026

OtherAPGEcash flow metrics

Quarterly FCF

-$54.26M
APGE quarterly free cash flow is -$54.26 million

Quarterly CFO

-$54.26M
APGE quarterly cash from operations is -$54.26 million

Quarterly CFI

$17.95M
APGE quarterly cash from investing is $17.95 million

Quarterly CFF

$19.74M
APGE quarterly cash from financing is $19.74 million

TTM CAPEX:

$5.09M-$751.00K(-12.87%)
September 30, 2025

Summary

  • As of today, APGE TTM capital expenditures is $5.09 million, with the most recent change of -$751.00 thousand (-12.87%) on September 30, 2025.
  • Over the past year, APGE TTM CAPEX has increased by +$3.77 million (+285.30%).
  • APGE TTM CAPEX is now -12.87% below its all-time high of $5.84 million, reached on June 30, 2025.

Performance

3-Month Change

-12.87%

1-Year Change

+285.3%

3-Year Change

+100%

5-Year Change

+100%

APGE TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

70.46%
APGE TTM capital expenditures is higher than 70.46% of companies in Healthcare sector

Range

All-Time High

$5.84M
APGE TTM capital expenditures is currently -12.87% below its historical high of $5.84 million

3-Year Low

$0.00
APGE TTM capital expenditures is currently >+9900.00% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
APGE previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Mar 2, 2026
APGE next earnings announcement is scheduled for Mar 2, 2026

OtherAPGEcash flow metrics

TTM FCF

-$237.56M
APGE TTM free cash flow is -$237.56 million

TTM CFO

-$232.47M
APGE TTM cash from operations is -$232.47 million

TTM CFI

$155.42M
APGE TTM cash from investing is $155.42 million

TTM CFF

$65.90M
APGE TTM cash from financing is $65.90 million

APGE CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+589.8%-100.0%+285.3%
3Y3 Years+100.0%0.0%+100.0%
5Y5 Years+100.0%0.0%+100.0%

APGE CAPEX Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high>+9999.0%-100.0%at low-12.9%>+9999.0%
5Y5-Yearat high>+9999.0%-100.0%at low-12.9%>+9999.0%
All-TimeAll-Timeat high>+9999.0%-100.0%at low-12.9%>+9999.0%

APGE CAPEX History

DateAnnualQuarterlyTTM
Sep 2025
-
$0.00(-100.0%)
$5.09M(-12.9%)
Jun 2025
-
$768.00K(-82.2%)
$5.84M(+14.0%)
Mar 2025
-
$4.32M(>+9900.0%)
$5.12M(+343.7%)
Dec 2024
$1.15M(+589.8%)
$1000.00(-99.9%)
$1.15M(-12.6%)
Sep 2024
-
$751.00K(+1372.5%)
$1.32M(+132.0%)
Jun 2024
-
$51.00K(-85.5%)
$569.00K(+9.8%)
Mar 2024
-
$351.00K(+110.2%)
$518.00K(+210.2%)
DateAnnualQuarterlyTTM
Dec 2023
$167.00K(>+9900.0%)
$167.00K(>+9900.0%)
$167.00K(>+9900.0%)
Sep 2023
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2023
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2023
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2022
$0.00
-
-
Sep 2022
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2022
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2022
-
$0.00
$0.00

FAQ

  • What is Apogee Therapeutics, Inc. annual capital expenditures?
  • What is the all-time high annual CAPEX for Apogee Therapeutics, Inc.?
  • What is Apogee Therapeutics, Inc. annual CAPEX year-on-year change?
  • What is Apogee Therapeutics, Inc. quarterly capital expenditures?
  • What is the all-time high quarterly CAPEX for Apogee Therapeutics, Inc.?
  • What is Apogee Therapeutics, Inc. quarterly CAPEX year-on-year change?
  • What is Apogee Therapeutics, Inc. TTM capital expenditures?
  • What is the all-time high TTM CAPEX for Apogee Therapeutics, Inc.?
  • What is Apogee Therapeutics, Inc. TTM CAPEX year-on-year change?

What is Apogee Therapeutics, Inc. annual capital expenditures?

The current annual CAPEX of APGE is $1.15M

What is the all-time high annual CAPEX for Apogee Therapeutics, Inc.?

Apogee Therapeutics, Inc. all-time high annual capital expenditures is $1.15M

What is Apogee Therapeutics, Inc. annual CAPEX year-on-year change?

Over the past year, APGE annual capital expenditures has changed by +$985.00K (+589.82%)

What is Apogee Therapeutics, Inc. quarterly capital expenditures?

The current quarterly CAPEX of APGE is $0.00

What is the all-time high quarterly CAPEX for Apogee Therapeutics, Inc.?

Apogee Therapeutics, Inc. all-time high quarterly capital expenditures is $4.32M

What is Apogee Therapeutics, Inc. quarterly CAPEX year-on-year change?

Over the past year, APGE quarterly capital expenditures has changed by -$751.00K (-100.00%)

What is Apogee Therapeutics, Inc. TTM capital expenditures?

The current TTM CAPEX of APGE is $5.09M

What is the all-time high TTM CAPEX for Apogee Therapeutics, Inc.?

Apogee Therapeutics, Inc. all-time high TTM capital expenditures is $5.84M

What is Apogee Therapeutics, Inc. TTM CAPEX year-on-year change?

Over the past year, APGE TTM capital expenditures has changed by +$3.77M (+285.30%)
On this page